Brant Inman
Urology · Durham, NCNPI 1093795429
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $33,960 of the $55,383 with a category attached, or 61.3%. It is spread thinly across 17 manufacturers, the largest accounting for just 16.3%. Reporting peaked in 2021 at $19,945 and has fallen 99.7% since, to $68 in 2025. Among urology clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 83 payments — averaging $667.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biom'up France SAS$9K
- Ferring Pharmaceuticals Inc.$7K
- Ferring Inc.$7K
- Urogen Pharma, Inc.$6K
- Medtronic$6K
- Seagen Inc.$5K
- plus $15K from 11 others
Across 71 payments — averaging $5451.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- QED Therapeutics, Inc.$105K
- Seagen Inc.$103K
- Janssen Research & Development, LLC$83K
- Genentech, Inc.$57K
- F. Hoffmann-la Roche AG$35K
- E.r. Squibb & Sons, L.L.C.$2K
- plus $2K from 2 others
What the payments were for
- Consulting fees$33,96061%
- Speaking & faculty fees$11,99022%
- Travel & lodging$6,52312%
- Food & beverage$2,9095%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biom'up France SAS | 3 | $9,000 |
| Ferring Pharmaceuticals Inc. | 6 | $7,360 |
| Ferring Inc. | 5 | $6,721 |
| Urogen Pharma, Inc. | 2 | $6,458 |
| Medtronic | 32 | $6,122 |
| Seagen Inc. | 3 | $5,170 |
| E.r. Squibb & Sons, L.L.C. | 1 | $3,840 |
| Janssen Research & Development, LLC | 3 | $3,575 |
| Eisai Inc. | 2 | $3,500 |
| Pfizer | 1 | $1,400 |
| Tersera Therapeutics LLC | 14 | $658 |
| Johnson & Johnson | 1 | $505 |
| Boston Scientific | 4 | $427 |
| Photocure Inc | 3 | $321 |
| Olympus America Inc. | 1 | $144 |
| Genentech, Inc. | 1 | $105 |
| Blue Earth Diagnostics | 1 | $77 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HemoBlast Bellows$9,000
- JELMYTO$6,400
- PADCEV$5,043
- OPDIVO$3,840
- LENVIMA$3,500
- INLYTA$1,400
- ZOLADEX$392
- LithoVue$291
- VersaOne$189
- Cysview$152
- iTIND System$144
- VALLEYLAB FT10$128
- LigaSure$105
- TECENTRIQ$105
- ENDO GIA ULTRA$105
- GENERAL KIDNEY STONE DISEASE$101
How this compares
$55,383 in reported general payments places this provider in the 90th percentile of 434 urology providers in North Carolina.
Other urology in Durham
- Judd MoulDurham$1M
- Daniel GeorgeDurham$1M
- Glenn PremingerDurham$736K
- Michael LipkinDurham$293K
- Jay KimDurham$202K
- Andrew PetersonDurham$124K
- Cary RobertsonDurham$76K
- Thomas PolascikDurham$54K
- Robert MedairosDurham$27K
- Edward HouserDurham$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.